July 12, 2018
Regenerative Medicine Advisory Board

BioBridge Global today announced the formation of a new Regenerative Medicine Advisory Board, composed of industry leaders with a wide range of scientific, product development and business experience, to support the organization’s continued growth in regenerative medicine.  

BioBridge Global provides a wide range of blood, tissue and cellular source materials, products and services through its three operating entities: GenCure, QualTex Laboratories and the South Texas Blood & Tissue Center. These include blood and tissue collection, processing and distribution, biological testing, process engineering and biomanufacturing.

The initial members of the BioBridge Global Regenerative Medicine Advisory Board are:

Announcements